Related references
Note: Only part of the references are listed.Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness
Changhong Tan et al.
ATHEROSCLEROSIS (2014)
Increased plasma DPP4 activities predict new-onset atherosclerosis in association with its proinflammatory effects in Chinese over a four year period: A prospective study
T. P. Zheng et al.
ATHEROSCLEROSIS (2014)
Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability
Daiane Silvello et al.
BIOMARKERS (2014)
Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of. radiolabeled inhibitors as imaging agents for plaque vulnerability
Adrienne Mueller et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Serum SPARC and Matrix Metalloproteinase-2 and Metalloproteinase-9 Concentrations after Bariatric Surgery in Obese Adults
Yeon Ji Lee et al.
OBESITY SURGERY (2014)
Bioinformatics tools for secretome analysis
Dario Caccia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Adipose Dipeptidyl Peptidase-4 and Obesity Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
Henrike Sell et al.
DIABETES CARE (2013)
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
Nasib Ervinna et al.
ENDOCRINOLOGY (2013)
cAMP-response Element-binding Protein (CREB) and NF-κB Transcription Factors Are Activated during Prolonged Hypoxia and Cooperatively Regulate the Induction of Matrix Metalloproteinase MMP1
Koh Nakayama
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Identification and Validation of Novel Contraction-Regulated Myokines Released from Primary Human Skeletal Muscle Cells
Silja Raschke et al.
PLOS ONE (2013)
The Role of DPP4 Activity in Cardiovascular Districts: In Vivo and In Vitro Evidence
L. Pala et al.
JOURNAL OF DIABETES RESEARCH (2013)
Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-α
Yuko Yamamoto et al.
HEART AND VESSELS (2012)
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
Matthew R. Alexander et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers et al.
DIABETES (2011)
Incretin effect: GLP-1, GIP, DPP4
Kyriakos Kazakos
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
The A Disintegrin And Metalloproteases ADAM10 and ADAM17: Novel drug targets with therapeutic potential?
Paul Saftig et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
Gian Paolo Fadini et al.
VASCULAR PHARMACOLOGY (2011)
Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-Dependent Prostate Cancer Cell Migration
Aaron L. Sabbota et al.
CANCER RESEARCH (2010)
Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells
A. S. Ribeiro et al.
ONCOGENE (2010)
On the origin of serum CD26 and its altered concentration in cancer patients
Oscar J. Cordero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
MMP-1 serum levels predict coronary atherosclerosis in humans
Michael Lehrke et al.
CARDIOVASCULAR DIABETOLOGY (2009)
The role of hypoxia in atherosclerosis
Lillemor Mattsson Hulten et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis
Xin Lu et al.
GENES & DEVELOPMENT (2009)
Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets
Stephan Reinboldt et al.
PLATELETS (2009)
Matrix metalloproteinase-2 and-9 levels in obese patients
G. Derosa et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2008)
A novel technique to propagate primary human preadipocytes without loss of differentiation capacity
Thomas Skurk et al.
OBESITY (2007)
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
Pablo Aschner et al.
DIABETES CARE (2006)
Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors
D Dietze-Schroeder et al.
DIABETES (2005)
MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices
WB Saunders et al.
JOURNAL OF CELL SCIENCE (2005)
Regulation of matrix metalloproteinases: An overview
S Chakraborti et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes
M Toth et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The mystery of nonclassical protein secretion - A current view on cargo proteins and potential export routes
W Nickel
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation
C Chavey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity
E Fiore et al.
ONCOGENE (2002)
Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity
E Maquoi et al.
DIABETES (2002)
Share Paper
